This is a preview of subscription content, log in via an institution to check access.
Reference
Daniel S, et al. Thyroid dysfunction after Alemtuzumab treatment for multiple sclerosis: A report of four cases. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine 73 (Suppl. 2): 57-58, 2018. Available from: URL: http://doi.org/10.1080/17843286.2018.1542267 [abstract] -Belgium
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1737, 22 (2019). https://doi.org/10.1007/s40278-019-57117-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57117-9